The scale of the new arms package
The Trump administration is preparing to send powerful 2,000‑lb munitions to Israel under a $2.8 billion deal that would add 40,000 bombs to the Israeli arsenal. According to four sources who spoke on condition of anonymity, the shipment consists of 20,000 MK‑84 bombs and an equal number of BLU‑117 variants. The weapons are to be financed through the US foreign military financing programme, meaning American taxpayers will indirectly foot the bill while Israel purchases the ordnance from American manufacturers. Congressional staff have been briefed informally about the pending arrangement, which has not yet been finalised.
Political backdrop and previous holds
The proposed sale marks a reversal of a decision taken by the Biden team in 2024, when delivery of the same type of bombs was paused over concerns about mass casualties in Gaza. When Donald Trump returned to the White House, his administration lifted that restriction and accelerated a series of arms transfers. Last year, the Trump officials bypassed the usual congressional review process to approve a nearly $3 billion sale that included more than 35,500 of the 2,000‑lb bombs. In January, a further $6.67 billion in arms sales to Israel was sanctioned, reinforcing a pattern of expanding military support.
The latest package comes as Israel faces growing diplomatic pressure over its campaign in Gaza. The United Nations estimates that tens of thousands of Palestinians have lost their lives since the conflict began in October 2023. A fragile US‑brokered ceasefire has been repeatedly breached, adding to the humanitarian toll.
Impact on the Gaza conflict
Experts tracking the war have linked the use of US‑made 2,000‑lb bombs to strikes in densely populated areas of Gaza. Analysis of blast remnants and aerial footage suggests that both deep‑penetration and air‑burst variants have been employed, targeting Hamas tunnel networks but also causing widespread destruction in residential zones. The Gaza health ministry puts the Palestinian death toll at more than 73,264, a figure that includes casualties incurred during periods when a ceasefire was nominally in effect.
The Hamas attack on 7 October 2023 killed roughly 1,200 Israelis and resulted in the capture of 251 hostages. Israel’s subsequent military response has been heavily reliant on advanced weaponry supplied by the United States. While the Israeli Defence Forces have offered limited public detail on the munitions they use, the prevalence of US‑made bombs has been documented by independent analysts and human‑rights researchers.
Strategic and diplomatic ramifications
The new arms deal underscores a broader shift in US policy toward bolstering Israel’s military capabilities, even as the conflict drags on and international opinion turns increasingly critical. By utilising foreign military financing, the administration sidesteps direct budgetary scrutiny while maintaining a steady flow of high‑technology weapons to its ally. This approach has sparked debate in Congress and among advocacy groups, who argue that the sales may exacerbate civilian suffering and complicate efforts to negotiate a lasting settlement.
In addition to the immediate humanitarian concerns, the shipment raises questions about America’s role in regional stability. Critics contend that supplying powerful bombs without stringent safeguards could fuel a cycle of violence, while supporters maintain that the weapons are essential for Israel’s self‑defence against terrorist threats. The deal also reflects a strategic calculus that prioritises military deterrence over diplomatic engagement at a time when the United States is seeking to recalibrate its Middle‑East policy.
Why it Matters
The forthcoming delivery of 2,000‑lb bombs to Israel signals a significant escalation of US involvement in the Gaza war, reversing a previous pause and reinforcing a pattern of expansive arms transfers under the Trump administration. The $2.8 billion package not only supplies a substantial quantity of munitions but also highlights the use of foreign military financing to circumvent tighter congressional oversight. For Gaza’s civilians, the arrival of these powerful weapons could mean further loss of life and heightened destruction in an already devastated territory. For US foreign policy, the move underscores a strategic bet on military aid as a tool of alliance management, even as the conflict’s human cost mounts and international condemnation grows. The decision will likely shape the trajectory of the war, the prospects for a sustainable ceasefire, and America’s standing in the broader Middle‑East diplomatic landscape.
